Clinical trials: Peripheral Primitive Neuroectodermal Tumor
Metastatic Medulloblastoma, High Risk Supratentorial PNET
Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)
The purpose of this study is to study the efficacy of the combination of reduced dose craniospinal radiation (reduced from standard of care dosing at 36 Gy to 24 Gy) with concurrent carboplatin and vincristine administration for…
- Conditions
- Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET
- Trial name
- NCT01542736
- Testing
- Carboplatin, Vincristine, 24 Gy
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- University of Colorado, Denver